Sirtinol inhibits SIRT1 and increases the acetylation of tumor suppressor proteins, such as p53, thereby inducing apoptosis and autophagic cell death in various cancer cells, including breast cancer [86,122]. This evidence concerns the gene TP53 and breast carcinoma.